ask="N/A"
ask_size="N/A"
average_daily_volume="588940"
bid="57.00"
bid_size="200"
book_value="9.91"
change="-0.03"
change_from_200_day_moving_average="15.44"
change_from_50_day_moving_average="9.29"
change_from_52_week_high="-3.70"
change_From_52_week_low="36.02"
change_in_percent="-0.05%"
close="62.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.20"
ebitda="-159.90M"
eps_estimate_current_year="-6.34"
eps_estimate_next_quarter="-1.56"
eps_estimate_next_year="-5.27"
ex_dividend_date="N/A"
float_shares="33673000"
high="62.97"
high_52_weeks="66.00"
last_trade_date="2/24/2017"
last_trade_price="62.30"
last_trade_size="29472"
last_trade_time="4:00pm"
low="60.52"
low_52_weeks="26.28"
market_capitalization="2.32B"
moving_average_200_day="46.86"
moving_average_50_day="53.01"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="83.09"
open="61.63"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+32.94%"
percent_change_from_50_day_moving_average="+17.53%"
percent_change_from_52_week_high="-5.61%"
percent_change_from_52_week_low="+137.06%"
previous_close="62.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.29"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37198000"
short_ratio="8.74"
stock_exchange="NGM"
symbol="SAGE"
volume="528959"
weeks_range_52="26.28 - 66.00"
